🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xiaohu Zhang

Hunan University

ORCID: 0000-0002-5329-1599

Also affiliated with Soochow University, China International Engineering Design & Research Institute, National Center for Advancing Translational Sciences, China Agricultural University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments”.

Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments

Genes Chromosomes and Cancer(2020)10.1002/gcc.22847
N/A
0DataRank · unranked
17 citations

Youfeng Yang, Christopher J. Ricketts, Cathy D. Vocke, Mark W. Ball, Carole Sourbier +12 more

Overcoming Acquired Epigenetic Resistance to BTK Inhibitors

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0063
N/A
0DataRank · unranked
61 citations

James D. Phelan, James Q. Wang, Dawei Huang, George W. Wright, Monica Kasbekar +26 more

Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex

Nature Communications(2023)10.1038/s41467-023-39374-9
N/A
0DataRank · unranked
28 citations

Simone A. Baechler, Xiaohu Zhang, Suresh Kumar, Valentina M. Factor, Yasuhiro Arakawa +20 more

High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma

Journal of Experimental & Clinical Cancer Research(2023)10.1186/s13046-023-02667-4
N/A
0DataRank · unranked
20 citations

Laura S. Schmidt, Kelli M. Wilson, Christopher J. Ricketts, Carole Sourbier, Cathy D. Vocke +23 more

Preclinical validation of a novel therapeutic strategy for choroid plexus carcinoma

Journal of Controlled Release(2023)10.1016/j.jconrel.2023.04.016
N/A
0DataRank · unranked
6 citations

Tyler Garman, Madeline Laramee, Amy Wang, Xiaohu Zhang, Erin Beck +10 more

Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma

Cancer Letters(2023)10.1016/j.canlet.2023.216284
N/A
0DataRank · unranked
10 citations

Snehal Gaikwad, Wendy Dubois, Nana Gyabaah-Kessie, Shuling Zhang, Sayeh Gorjifard +27 more

Data from Targeting the PI3K/mTOR Pathway Augments CHK1 Inhibitor–Induced Replication Stress and Antitumor Activity in High-Grade Serous Ovarian Cancer

(2023)10.1158/0008-5472.c.6512107
N/A
0DataRank · unranked
0 citations

Ethan Brill, Jayakumar R. Nair, Xiaohu Zhang, Kelli M. Wilson, Lu Chen +3 more

Data from Targeting the PI3K/mTOR Pathway Augments CHK1 Inhibitor–Induced Replication Stress and Antitumor Activity in High-Grade Serous Ovarian Cancer

(2023)10.1158/0008-5472.c.6512107.v1
N/A
0DataRank · unranked
0 citations

Ethan Brill, Jayakumar R. Nair, Xiaohu Zhang, Kelli M. Wilson, Lu Chen +3 more

Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer

Nature Communications(2025)10.1038/s41467-025-64042-5
N/A
0DataRank · unranked
6 citations

Daniel Westaby, Ines Figueiredo, Alexis de Haven Brandon, Ana Padilha, Wei Yuan +53 more

An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors

ACS Pharmacology & Translational Science(2025)10.1021/acsptsci.5c00412
N/A
0DataRank · unranked
2 citations

Xiaohu Zhang, Patricia Alfonso, Patrick J. Morris, Carleen Klumpp‐Thomas, Christopher Melani +12 more